Standout Papers
Citation Impact
Citing Papers
Randomised clinical trials: linaclotide phase 3 studies in IBS ‐C – a prespecified further analysis based on European Medicines Agency‐specified endpoints
2012
Estimating medication persistency using administrative claims data.
2005
Stability of the irritable bowel syndrome and subgroups as measured by three diagnostic criteria – a 10‐year follow‐up study
2010
Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART I
2016 Standout
Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome
2011
The Global Burden of Skin Disease in 2010: An Analysis of the Prevalence and Impact of Skin Conditions
2013 Standout
Role of the normal gut microbiota
2015 Standout
Pathogen-specific risk of chronic gastrointestinal disorders following bacterial causes of foodborne illness
2013
Medication persistence over 2 years of follow-up in a cohort of early rheumatoid arthritis patients: associated factors and relationship with disease activity and with disability
2009
Adherence with statins in a real-life setting is better when associated cardiovascular risk factors increase: a cohort study
2011
Primary Medication Non-Adherence: Analysis of 195,930 Electronic Prescriptions
2010
A new taxonomy for describing and defining adherence to medications
2012 Standout
New treatments for IBS
2012
Application of Rasch Analysis in the Development and Application of Quality of Life Instruments
2004
Nonadherence in outpatient thromboprophylaxis after major orthopedic surgery: a systematic review
2010
Functional Bowel Disorders
2006 Standout
Gut memories: Towards a cognitive neurobiology of irritable bowel syndrome
2011
Rheumatoid arthritis
2018 Standout
The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results
2008 Standout
Bowel Disorders
2016 Standout
Self-management for women with irritable bowel syndrome
2004
Comparison of measures of medication persistency using a prescription drug database
2006
Toward a standard definition and measurement of persistence with drug therapy: Examples from research on statin and antihypertensive utilization
2006
Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C–Related Compensated Cirrhosis
2015
Dietary Triggers of Abdominal Symptoms in Patients With Irritable Bowel Syndrome: Randomized Placebo-Controlled Evidence
2008
Microbial tryptophan catabolites in health and disease
2018 Standout
Adapting Quality of Life Instruments
2004
Effects of multidisciplinary education on outcomes in patients with irritable bowel syndrome
2004
Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society
2007 Standout
Prevention of VTE in Orthopedic Surgery Patients
2012 Standout
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
2009 Standout
Pharmacologic and Complementary and Alternative Medicine Therapies for Irritable Bowel Syndrome
2011
Atopic dermatitis
2015 Standout
Severe irritable bowel and functional abdominal pain syndromes: Managing the patient and health care costs
2005
Impact of Adherence to Antihypertensive Agents on Clinical Outcomes and Hospitalization Costs
2010
Acupuncture for Irritable Bowel Syndrome: Systematic Review and Meta-Analysis
2012
Cost-effectiveness of enhancing adherence to therapy with statins in the setting of primary cardiovascular prevention. Evidence from an empirical approach based on administrative databases
2011
Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome
2008 Standout
Efecto de la actuación farmacéutica en la adherencia del tratamiento farmacológico de pacientes ambulatorios con riesgo cardiovascular (Estudio EMDADER-CV-INCUMPLIMIENTO)
2011
Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: Baseline results from logic (longitudinal outcomes study of gastrointestinal symptoms in Canada), a naturalistic study
2006
Measuring quality of life of patients with different clinical types of psoriasis using the SF-36
2006
Measuring symptoms in the irritable bowel syndrome: development of a framework for clinical trials
2010
Trends in blood pressure control and treatment among type 2 diabetes with comorbid hypertension in the United States: 1988–2004
2009
Prevention of VTE in Nonsurgical Patients
2012 Standout
Irritable bowel syndrome
2016 Standout
Irritable Bowel Syndrome and Microscopic Colitis: A Systematic Review and Meta-analysis
2015
Irritable bowel syndrome: A microbiome-gut-brain axis disorder?
2014
Diabetic Retinopathy
2012 Standout
Relationship between Adherence Level to Statins, Clinical Issues and Health-Care Costs in Real-Life Clinical Setting
2009
Portal hypertensive bleeding in cirrhosis
2016 Standout
The Functional Gastrointestinal Disorders and the Rome III Process
2006 Standout
Risk factors for suicidal thoughts and behaviors: A meta-analysis of 50 years of research.
2016 Standout
A Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome
2013 Standout
Osteoporosis Telephonic Intervention to Improve Medication Regimen Adherence
2012
Medication Adherence and Persistence as the Cornerstone of Effective Antihypertensive Therapy
2006
Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors?
2010
Definition and Classification of Irritable Bowel Syndrome: Current Consensus and Controversies
2005
Cognitive performance in irritable bowel syndrome: evidence of a stress-related impairment in visuospatial memory
2013
Systematic review: the efficacy of treatments for irritable bowel syndrome – a European perspective
2006
The economic impact of irritable bowel syndrome
2003
Life quality assessment among patients with atopic eczema
2005
Burden of skin diseases
2009
Better compliance to antihypertensive medications reduces cardiovascular risk
2010
Impact of better adherence to statin agents in the primary prevention of coronary artery disease
2009
Severity in Irritable Bowel Syndrome: A Rome Foundation Working Team Report
2011
The Efficacy and Safety of Rifaximin for the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis
2011
Atopic Dermatitis/Atopic Eczema
2014
Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome as Well as Traditional Dietary Advice: A Randomized Controlled Trial
2015 Standout
Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact
2005
Diagnostic criteria in IBS: useful or not?
2012
Guided self-help interventions for irritable bowel syndrome
2015
The burden of IBS: Looking at metrics
2009
Racial differences in long-term adherence to oral antidiabetic drug therapy: a longitudinal cohort study
2009
Clinical trial: short‐ and long‐term benefit of relaxation training for irritable bowel syndrome
2007
Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): Extending the CONSORT Statement
2010 Standout
Costs of Irritable Bowel Syndrome in the UK and US
2006
Guidelines on the irritable bowel syndrome: mechanisms and practical management
2007
The Prevalence of Celiac Disease Among Patients With Nonconstipated Irritable Bowel Syndrome Is Similar to Controls
2011
Serotonin, tryptophan metabolism and the brain-gut-microbiome axis
2014 Standout
The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review
2007
Update on Irritable Bowel Syndrome and Gender Differences
2008
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
2012 Standout
Relationship of Blood Pressure Control to Adherence With Antihypertensive Monotherapy in 13 Managed Care Organizations
2006
Prevalence of irritable bowel syndrome in Italian rural and urban areas
2010
Clinical and economic consequences of medication non-adherence in the treatment of patients with a manic/mixed episode of bipolar disorder: Results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) Study
2011
Update on Key Emerging Challenges in Cystic Fibrosis
2014 Standout
Critical Review of Generic and Dermatology-Specific Health-Related Quality of Life Instruments
2007
Irritable bowel syndrome and surgery: A multivariable analysis☆
2004
Medication Adherence: WHO Cares?
2011 Standout
Design of Treatment Trials for Functional Gastrointestinal Disorders
2016
The Family Dermatology Life Quality Index: measuring the secondary impact of skin disease
2006
The epidemiological aspects of irritable bowel syndrome in Southeastern Anatolia: a stratified randomised community-based study
2005
Direct and indirect costs of nephrolithiasis in an employed population: Opportunity for disease management?
2005
Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
2012 Standout
Impact of supportive measures on drug adherence in patients with essential hypertension treated with valsartan: the randomized, open-label, parallel group study VALIDATE
2009
Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis
2008 Standout
A Positive Diagnostic Strategy Is Noninferior to a Strategy of Exclusion for Patients With Irritable Bowel Syndrome
2013
The Intestinal Microbiota Affect Central Levels of Brain-Derived Neurotropic Factor and Behavior in Mice
2011 Standout
Diagnosis and management of IBS
2010
A Refill Adherence Algorithm for Multiple Short Intervals to Estimate Refill Compliance (ReComp)
2007
Neurodevelopmental Outcomes of Very Low-Birth-Weight Infants With Necrotizing Enterocolitis
2007
Prevalence of Kidney Stones in the United States
2012 Standout
Irritable Bowel Syndrome
2015 Standout
Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome
2012
Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets
2014
Safety and Efficacy of Novel Oral Anticoagulants Versus Warfarin in Medicare Beneficiaries With Atrial Fibrillation and Valvular Heart Disease
2018
Medical Management of Kidney Stones: AUA Guideline
2014 Standout
The Effect of Irritable Bowel Syndrome on Health-Related Quality of Life and Health Care Expenditures
2011
Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol
2019 Standout
Adherence to Antihypertensive Medications and Cardiovascular Morbidity Among Newly Diagnosed Hypertensive Patients
2009
Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
2006
Irritable bowel syndrome
2004
Irritable bowel syndrome in adults over 35 years in Shiraz, southern Iran: prevalence and associated factors.
2011
Gut microbiota are related to Parkinson's disease and clinical phenotype
2014 Standout
Chapter 4European guidelinesfor the management of chronicnonspecific low back pain
2006 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Global Epidemiology of Campylobacter Infection
2015 Standout
Interventions for enhancing medication adherence
2014 Standout
Emerging Treatment Options in Mild to Moderate Ulcerative Colitis.
2015
Measurement of Adherence in Pharmacy Administrative Databases: A Proposal for Standard Definitions and Preferred Measures
2006
Acupuncture for Irritable Bowel Syndrome – An Exploratory Randomised Controlled Trial
2008
Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome â a longitudinal study in IBS and control subjects
2004
Management of lipid-lowering therapy in patients with cardiovascular events in the UK: a retrospective cohort study
2017
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Adherence to Statin Therapy Under Drug Cost Sharing in Patients With and Without Acute Myocardial Infarction
2007
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Medication Adherence
2009 Standout
Medication Adherence Measures: An Overview
2015 Standout
Racial-Ethnic Disparities in Stroke Care: The American Experience
2011 Standout
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout
Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV
2016 Standout
Works of Feride Frech being referenced
A comparison of office-based physician visits for irritable bowel syndrome and for migraine and asthma.
2002
Patient Adherence With Amlodipine, Lisinopril, or Valsartan Therapy in a Usual-Care Setting
2003
International development of the Parents’ Index of Quality of Life in Atopic Dermatitis (PIQoL-AD)
2005
Assessment of Drug Therapy Management and the Prevalence of Heart Failure in a Managed Care Population With Hypertension
2004
Methods for evaluation of medication adherence and persistence using automated databases
2006 Standout
Utilization patterns and net direct medical cost to Medicaid of irritable bowel syndrome
2003
A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD)
2004
Irritable Bowel Syndrome, Health Care Use, and Costs: A U.S. Managed Care Perspective
2003
The need for improved medical management of patients with concomitant hypertension and type 2 diabetes mellitus.
2005
Impairment in work productivity and health-related quality of life in patients with IBS.
2005
Determinants of uncontrolled hypertension in an African-American population.
2002
The economic consequences of irritable bowel syndrome: a US employer perspective.
2003
Quality of life in managed care patients with irritable bowel syndrome.
2004